Analysis of the combinatorial anti-proliferative effect of panRAF inhibitor AZ-628 and MEK1 inhibitor AZD-6244 (selumetinib) on a large panel of tumor cell lines 2017, presented at AACR by Andrew Khouri | Jul 6, 2023
Characterization of KRas pathway inhibitors in 2D and 3D screening formats by Andrew Khouri | Jul 6, 2023
